Ombretta Turriziani

Pubblicazioni

Titolo Pubblicato in Anno
Infectious agents in atherosclerotic cardiovascular diseases through oxidative stress INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2017
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013–2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE 2017
Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy JOURNAL OF MEDICAL VIROLOGY 2016
ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response IMMUNOBIOLOGY 2016
First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testing JOURNAL OF CLINICAL VIROLOGY 2016
Evaluation of a commercial real-time PCR kit for the detection of the Q80K polymorphism in plasma from HCV genotype 1a infected patients JOURNAL OF CLINICAL VIROLOGY 2016
Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to TypingHLA-B*57:01in HIV-1-Positive Patients AIDS RESEARCH AND HUMAN RETROVIRUSES 2016
Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment THROMBOSIS AND HAEMOSTASIS 2016
Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia NEW MICROBIOLOGICA 2016
IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection ARCHIVES OF VIROLOGY 2016
Analysis of the mRNA expression of DNA damage response genes in HIV infected patients JOURNAL OF CLINICAL VIROLOGY 2016
MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients BMC INFECTIOUS DISEASES 2015
Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the "Probio-HIV" Clinical Trial PLOS ONE 2015
Backbone switch to abacavir/lamivudine fixed-dose combination: implications for antiretroviral therapy optimization NEW MICROBIOLOGICA 2015
CMV load quantitation by the automated VERSANT k-PCR Molecular System in plasma of transplanted patients JOURNAL OF CLINICAL VIROLOGY 2015
Dynamics of HIV DNA and residual viremia in patients treated with a raltegravir-containing regimen. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2015
HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy. JOURNAL OF MEDICAL VIROLOGY 2015
An epidemiological investigation to reconstruct a probable human immunodeficiency virus-1 transmission network: a case report JOURNAL OF MEDICAL CASE REPORTS 2015
Trends in drug resistance-associated mutations in a real-life cohort of Italian patients infected with HIV-1 JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE 2015

ERC

  • LS6_5

Interessi di ricerca

L’infezione da SARS-CoV-2: diagnosi molecolare e gestione del paziente
Resistenza alla terapia antiretrovirale: effetti a lungo termine della terapia antiretrovirale sulla cellula e studio dei meccanismi di resistenza cellulare selezionati dopo trattamento. Ruolo dell’espressione di trasportatori di membrana nella resistenza ai farmaci antiretrovirali. Caratterizzazione in vitro di ceppi di HIV farmacoresistenti. Studio delle varianti di HIV-1 farmacoresistenti in soggetti HIV positivi e analisi del possibile ruolo delle varianti di HIV farmacoresistenti archiviate nei serbatoi cellulari, nel fallimento della terapia antivirale.
Significato clinico della viremia residua in HIV: studi volti ad identificare sia i fattori che contribuiscono alla presenza di viremia residua, sia la relazione esistente tra viremia residua e immunoattivazione/infiammazione cronica.
nel soggetto HIV positivo.
Latenza di HIV: Effetti della terapia antiretrovirale sui serbatoi cellulari del virus.
Diagnosi virologica: Studi volti alla validazione e “messa a punto” di test diagnostici. Analisi comparative di test diagnostici commerciali

Keywords

SARS- CoV-2
antiretroviral therapy hiv
HIV latency
drug resistance
antiretroviral therapy hiv

Gruppi di ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma